MEDICXI
Medicxi is an international investment firm focused on the life sciences sector. It was established in 2016 by the former Index Ventures life sciences team, who have been active for over 20 years and have significant experience in drug discovery and the development of therapeutics for unmet medical needs.
MEDICXI
Industry:
Biopharma Biotechnology Life Science Venture Capital
Founded:
2016-02-01
Status:
Active
Contact:
+44 20 7952 1788
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics
Similar Organizations
Benaruca
Benaruca is a life science investment firm.
Cavalry Ventures
Cavalry is a Berlin-based early-stage Venture Capital fund.
Emerging Technology Partners
Emerging Technology Partners is a life sciences focused investment firm.
Perwyn
Perwyn is an entrepreneurial, privately-funded investment firm.
Steadview Capital
Steadview is a tech-focused investment firm that invests in technology oriented businesses.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-29 | MiroBio | Medicxi investment in Series B - MiroBio | 80 M GBP |
| 2021-09-08 | Xenikos | Medicxi investment in Convertible Note - Xenikos | 40 M EUR |
| 2021-08-31 | Versanis Bio | Medicxi investment in Series A - Versanis Bio | 70 M USD |
| 2021-08-10 | Sydnexis | Medicxi investment in Series B - Sydnexis | 45 M USD |
| 2021-07-20 | Rivus Pharmaceuticals | Medicxi investment in Series A - Rivus Pharmaceuticals | 35 M USD |
| 2021-06-10 | Kurome Therapeutics | Medicxi investment in Series A - Kurome Therapeutics | 15 M USD |
| 2021-03-22 | Aura Biosciences | Medicxi investment in Venture Round - Aura Biosciences | 80 M USD |
| 2020-10-07 | Janpix | Medicxi investment in Series B - Janpix | 10 M USD |
| 2020-09-25 | Palladio Biosciences | Medicxi investment in Series B - Palladio Biosciences | 20 M USD |
| 2020-06-10 | Checkmate Pharmaceuticals | Medicxi investment in Series C - Checkmate Pharmaceuticals | 85 M USD |